ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 82 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $229,000 | -38.9% | 25,200 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $375,000 | -35.9% | 25,200 | +10.5% | 0.00% | -50.0% |
| Q3 2021 | $585,000 | -1.5% | 22,800 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $594,000 | +88.6% | 22,800 | +82.4% | 0.00% | +100.0% |
| Q4 2020 | $315,000 | -30.9% | 12,500 | +3.3% | 0.00% | -50.0% |
| Q3 2020 | $456,000 | -26.0% | 12,100 | -16.0% | 0.00% | -33.3% |
| Q2 2020 | $616,000 | +268.9% | 14,400 | +148.3% | 0.00% | +200.0% |
| Q1 2019 | $167,000 | +7.1% | 5,800 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $156,000 | – | 5,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $26,829,000 | 10.04% |
| Wildcat Capital Management, LLC | 1,716,370 | $25,608,000 | 4.17% |
| TPG GP A, LLC | 18,716,306 | $279,247,000 | 2.79% |
| Casdin Capital, LLC | 2,650,000 | $39,538,000 | 1.11% |
| Lombard Odier Asset Management (Switzerland) SA | 996,116 | $14,862,000 | 0.95% |
| Coastal Bridge Advisors, LLC | 301,929 | $4,505,000 | 0.94% |
| HARBOR CAPITAL ADVISORS, INC. | 119,547 | $1,784,000 | 0.65% |
| Pier Capital, LLC | 294,968 | $4,401,000 | 0.46% |
| Navalign, LLC | 64,428 | $961,000 | 0.38% |
| Gratus Capital, LLC | 191,871 | $2,863,000 | 0.26% |